Mono-POC Ethyl Tenofovir
| Product Name | Mono-POC Ethyl Tenofovir |
|---|---|
| Alternate Names | Tenofovir Impurities, Impurities of Tenofovir |
| CAT No. | CS-O-11174 |
| CAS No. | 1796539-92-8 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 431.38 g/mol |
| Mol. For. | C16H26N5O7P |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Tenofovir |
| Purity | Not less than 90 % |
| Therapeutic | Antiretroviral / Anti-HIV |
| Smileys | C[C@@H](OC[P](OCOC(OC(C)C)=O)(OCC)=O)CN1C2=NC=NC(N)=C2N=C1 |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Mono-POC Ethyl Tenofovir is a novel prodrug of Tenofovir, which is used in the treatment of HIV and Hepatitis B virus infections. It is a nucleotide analog reverse transcriptase inhibitor that works by blocking the replication of the virus. Mono-POC Ethyl Tenofovir is designed to improve the bioavailability and pharmacokinetics of Tenofovir, thereby reducing the frequency of dosing and minimizing adverse effects.
The chemical structure of Mono-POC Ethyl Tenofovir consists of a phosphonamidate prodrug linked to a lipophilic ethyl group. The lipophilic nature of this compound allows for increased cellular uptake and better distribution into the target cells. The prodrug is selectively activated by esterases in the plasma and liver, releasing the active form of Tenofovir.
Mono-POC Ethyl Tenofovir is administered orally and has been studied in clinical trials for its safety and efficacy. It has shown promising results in reducing viral load and improving immune function in HIV-infected patients. Additionally, it has been found to be effective in the treatment of chronic Hepatitis B infections.
In conclusion, Mono-POC Ethyl Tenofovir is a prodrug of Tenofovir that has been designed to improve its bioavailability and pharmacokinetics. It has shown promising results in the treatment of HIV and Hepatitis B virus infections and may offer a safer and more effective alternative to current therapies.
Get an Instant Quote
Related Compounds
TAF SRS diastereomer | Tenofovir diphosphate | Tenofovir alafenamide Methyl ester impurity | Diisopropyl Tenofovir Fumarate | Tenofovir disoproxil phosphate | Tenofovir Disoproxil (S)-Isomer fumarate salt | Tenofovir Mixed dimer | Tenofovir Alafenamide fumarate | Tenofovir Alfenamide Amadori Rearrangement product | Tenofovir DP-IV | Tenofovir alafenamide (RRS) diasteroisomer | Tenofovir Alafenamide Dimer impurity | Tenofovir disoproxil impurity L fumarate | Tenofovir alafenamide monofumarate | Tenofovir alafenamide impurity | nPOC-POC Tenofovir Fumarate | Mono ester impurity (Tenofovir) | Mono-POC Tenofovir 6-Isopropyl Carbamate | Tenofovir Impurity 98 | Tenofovir Isopropyl Carbamate | Tenofovir Impurity 62 | Tenofovir DP-V | Tenofovir Impurity 65 | tenofovir related impurity | Diethylaminocarboxymethyl POC Tenofovir (Mixture of Diastereomers) | Desmethyl Tenofovir disoproxil | Tri-POC Tenofovir Dimer | Tenofovir alafenamide Impurity 5 | Tenofovir alafenamide lactose Millard Reaction product-3 | Tenofovir isomer 6&1 | Tenofovir Disoproxil T12 Impurity | Tenofovir Bis ((R)-9-(2-Hydroxypropyl)adenine) dimer Acetate salt | Tenofovir Disoproxil T5 Impurity | Tenofovir Impurity 59-D6 | nPOC-POC Tenofovir | Tenofovir Disoproxil Fumarate Impurity | Tenofovir EP Impurity C Succinate | Tenofovir Alafenamide N-hydroxy methyl impurity | Tenofovir Alafenamide (RSR) Diasteroisomer | Tenofovir impurity C fumarate salt | Mono-POC Methyl Tenofovir Fumarate (Mixture of Diastereomers) | Tenofovir alafenamide Impurity 2 | Tenofovir Disoproxil Isopropoxycarbonyl | Tenofovir Related Compound 5 | Tenofovir Mono POC Dimer Diethyl amine salt | Diethylaminocarboxymethyl POC Tenofovir Fumarate | Tenofovir Related Compound 14 | Tenofovir Disoproxil T8 Impurity | Tenofovir Impurity 89 | TAF Propyl ester Impurity | TAF methyl ester | Isopropyl Tenofovir | Tenofovir alafenamide lactose Millard Reaction product-2 | MOC-POC Tenofovir | Mono poc-isopropyl-Tenofovir fumarate salt | Tenofovir Alafenamide Glycosamine product | Tenofovir Impurity 59 | Desmethyl Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil T7 Impurity | Tenofovir Alafenamide Dimer Impurity II | Tenofovir Impurity 35 | Tenofovir Disoproxil T11 Impurity | Ethyl Tenofovir Impurity | Mono-POC Isopropyl Tenofovir | MOC-POC Tenofovir Fumarate | Tenofovir Mono-POC methyl ester | Tenofovir alafenamide Impurity 1 | Tenofovir Alafenamide Enantiomer | Tenofovir disoproxil impurity L | Tenofovir Monomethyl Ester |